Alzheimer’s Disease
Related
From Pipeline Progress to Precision Care: Five Takeaways from Two Leading MASH Conferences
Our team recently attended two leading forums focused on the future of MASH research and treatment: the 2026 Paris MASH Meeting and the 10th MASH Drug Development Summit in Boston. Together, the conferences brought perspectives from clinical pract...
Advancing Alzheimer’s Diagnosis and Research: A Conversation with Neurologist and Principal Investigator Lieza Exalto
For people experiencing changes in memory and thinking, and for those who support them, an Alzheimer’s diagnosis can bring difficult questions about independence, treatment, and the future. It can also provide a starting point for informed decis...
The Hidden Cost of Waiting to Rescue an At-Risk Clinical Trial
How sponsors can recognize material underperformance, diagnose root causes, and select the least disruptive path to recovery. Clinical trials rarely move from “on track” to “in crisis” overnight. Warning signs usually emerge gradually: si...